摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-amino-4-methoxythieno[2,3-b]pyridine-2-carboxylic acid | 1097202-22-6

中文名称
——
中文别名
——
英文名称
3-amino-4-methoxythieno[2,3-b]pyridine-2-carboxylic acid
英文别名
——
3-amino-4-methoxythieno[2,3-b]pyridine-2-carboxylic acid化学式
CAS
1097202-22-6
化学式
C9H8N2O3S
mdl
——
分子量
224.24
InChiKey
FMQSNWRXOFHGFC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    114
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    1,1-dicyano-4-(N,N-dimethylamino)-2-methoxy-1,3-butadiene氢溴酸溶剂黄146 、 potassium hydroxide 、 sodium hydroxide 作用下, 以 甲醇N,N-二甲基甲酰胺 为溶剂, 反应 50.0h, 生成 3-amino-4-methoxythieno[2,3-b]pyridine-2-carboxylic acid
    参考文献:
    名称:
    The Synthesis and Microbiological Activity of 2-Mercapto-4-methoxypyridine-3-carbonitrile Derivatives
    摘要:
    Synthesis of 2-(3-cyano-4-methoxypyridin-2-ylthio)acetic acid derivatives, starting either from 2-bromo-4-methoxypyridine-3-carbonitrile or 2-mercapto-4-methoxypyridine-3-carbonitrile is reported. The obtained products could be transformed by intramolecular Thorpe-Ziegler cyclization to related thieno[2,3-b]pyridines. Diazotization of 3-amino-N-(4-chlorophenyl)-4-methoxythieno[2,3-b]pyridine-2-carboxamide resulted in formation of a suitable pyridothienotriazine derivative. Some of the prepared compounds demonstrated noticeable bacteriostatic or tuberculostatic activity.
    DOI:
    10.3987/com-08-11439
点击查看最新优质反应信息

文献信息

  • Methods of treating muscular dystrophy
    申请人:BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA, RENO
    公开号:US10206903B2
    公开(公告)日:2019-02-19
    Disclosed herein are α7β1 integrin modulatory agents and methods of using such to treat conditions associated with decreased α7β1 integrin expression or activity, including muscular dystrophy. In one example, methods for treating a subject with muscular dystrophy are disclosed. The methods include administering an effective amount of an α7β1 integrin modulatory agent to the subject with muscular dystrophy, wherein the α7β1 integrin modulatory agent increases α7β1 integrin expression or activity as compared to α7β1 integrin expression or activity prior to treatment, thereby treating the subject with muscular dystrophy. Also disclosed are methods of enhancing muscle regeneration, repair, or maintenance in a subject and methods of enhancing α7β1 integrin expression by use of the disclosed α7β1 integrin modulatory agents. Methods of prospectively preventing or reducing muscle injury or damage in a subject are also disclosed.
    本文公开了α7β1整合素调节剂以及用其治疗与α7β1整合素表达或活性降低有关的疾病(包括肌肉萎缩症)的方法。在一个例子中,公开了治疗肌肉萎缩症患者的方法。该方法包括向肌肉萎缩症患者施用有效量的α7β1整合素调节剂,其中与治疗前的α7β1整合素表达或活性相比,α7β1整合素调节剂可增加α7β1整合素表达或活性,从而治疗肌肉萎缩症患者。还公开了增强受试者肌肉再生、修复或维持的方法,以及通过使用公开的α7β1整合素调节剂增强α7β1整合素表达的方法。还公开了预防或减少受试者肌肉损伤或损害的方法。
  • METHODS OF TREATING MUSCULAR DYSTROPHY
    申请人:BURKIN Dean
    公开号:US20160030390A1
    公开(公告)日:2016-02-04
    Disclosed herein are α7β1 integrin modulatory agents and methods of using such to treat conditions associated with decreased α7β1 integrin expression or activity, including muscular dystrophy. In one example, methods for treating a subject with muscular dystrophy are disclosed. The methods include administering an effective amount of an α7β1 integrin modulatory agent to the subject with muscular dystrophy, wherein the α7β1 integrin modulatory agent increases α7β1 integrin expression or activity as compared to α7β1 integrin expression or activity prior to treatment, thereby treating the subject with muscular dystrophy. Also disclosed are methods of enhancing muscle regeneration, repair, or maintenance in a subject and methods of enhancing α7β1 integrin expression by use of the disclosed α7β1 integrin modulatory agents. Methods of prospectively preventing or reducing muscle injury or damage in a subject are also disclosed.
  • US9707210B2
    申请人:——
    公开号:US9707210B2
    公开(公告)日:2017-07-18
  • US9980943B2
    申请人:——
    公开号:US9980943B2
    公开(公告)日:2018-05-29
  • The Synthesis and Microbiological Activity of 2-Mercapto-4-methoxypyridine-3-carbonitrile Derivatives
    作者:Agnieszka Miszke、Henryk Foks、Kamil Brożewicz、Anna Kędzia、Ewa Kwapisz、Zofia Zwolska
    DOI:10.3987/com-08-11439
    日期:——
    Synthesis of 2-(3-cyano-4-methoxypyridin-2-ylthio)acetic acid derivatives, starting either from 2-bromo-4-methoxypyridine-3-carbonitrile or 2-mercapto-4-methoxypyridine-3-carbonitrile is reported. The obtained products could be transformed by intramolecular Thorpe-Ziegler cyclization to related thieno[2,3-b]pyridines. Diazotization of 3-amino-N-(4-chlorophenyl)-4-methoxythieno[2,3-b]pyridine-2-carboxamide resulted in formation of a suitable pyridothienotriazine derivative. Some of the prepared compounds demonstrated noticeable bacteriostatic or tuberculostatic activity.
查看更多

同类化合物

钠3-氨基-4,6-二甲基噻吩并[2,3-b]吡啶-2-羧酸酯 脱乙酰基2-O-叔-丁基二甲基硅烷基普拉格雷 羟基(噻吩并[2,3-b]吡啶-3-基)乙腈 盐酸噻氯匹定 甲基4-溴7-氧-6,7-二氢噻吩并[2,3-C]吡啶-2-羧酸酯 甲基3-甲基噻吩并[2,3-c]吡啶-2-羧酸酯 甲基3-氨基噻吩并[2,3-c]吡啶-2-羧酸酯 甲基3-氨基-4-(二甲基氨基)噻吩并[2,3-b]吡啶-2-羧酸酯 甲基3-氨基-4,5,6-三甲基噻吩并[2,3-b]吡啶-2-羧酸酯 甲基2,4-二甲基噻吩并[3,4-b]吡啶-7-羧酸酯 替诺立定 普拉格雷羟基硫内酯 普拉格雷盐酸盐 普拉格雷杂质III 普拉格雷杂质1 普拉格雷杂质 普拉格雷 外消旋-2-(2-氯苯基)-(6,7-二氢-4H-噻吩并[3,2-c]吡啶-5-基)乙腈 噻氯吡啶杂质F 噻氯吡啶杂质E 噻氯匹定杂质8 噻氯匹定N-氧化物 噻氯匹定3-氯异构体 噻氯匹定 噻氯匹丁-d4 噻吩并吡啶酮 噻吩并吡啶-2-甲酸甲酯 噻吩并[3,4-b]吡啶-5,7-二酮 噻吩并[3,2:3,4]环戊二烯并[1,2-b]吖丙因(9CI) 噻吩并[3,2-c]吡啶-3-胺 噻吩并[3,2-c]吡啶-3-羧醛 噻吩并[3,2-c]吡啶-2-羧酸甲酯 噻吩并[3,2-c]吡啶-2-羧酸 噻吩并[3,2-c]吡啶-2-基硼酸 噻吩并[3,2-c]吡啶 噻吩并[3,2-b]吡啶-7-羧酸 噻吩并[3,2-b]吡啶-6-醇 噻吩并[3,2-b]吡啶-6-胺 噻吩并[3,2-b]吡啶-6-羧酸甲酯 噻吩并[3,2-b]吡啶-6-羧酸 噻吩并[3,2-b]吡啶-5-羧酸 噻吩并[3,2-b]吡啶-3-胺 噻吩并[3,2-b]吡啶-2-羧酸甲酯 噻吩并[3,2-b]吡啶-2-羧酸 噻吩并[3,2-b]吡啶-2-甲醇 噻吩并[3,2-C]吡啶-2-硼酸频那醇酯 噻吩并[3,2-B]吡啶-3-羧酸甲酯 噻吩并[2,3-c]吡啶-7-胺 噻吩并[2,3-c]吡啶-7-羧酸甲酯 噻吩并[2,3-c]吡啶-7-羧酸